BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学_第1页
BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学_第2页
BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学_第3页
BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学_第4页
BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学_第5页
已阅读5页,还剩48页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

BridgingtheCareGapContinuingMedicalImplementationInc桥接的保健差距实现公司继续医学©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregap当前1页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapCareGapFailureto,translate,transferandutilizemedicalknowledgeeffectively

UsualCare≠bestcarePopulationoutcomesdonotmatchresultsofclinicaltrialsPatient,physicians&payersdonotreapthebenefitsofvalidatedmedicalknowledge当前2页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapCareGapThedifferencebetweenwhatweknowandwhatwedoThedifferencebetweenachievableandactualoutcomesThefailuretosystematizeknowledgeandapplyitconsistently当前3页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapKnowledgeTranslation

Definition:“Knowledgetranslationistheeffectiveandtimelyincorporationofevidence-basedinformationintothepracticesofhealthprofessionalsinsuchawayastoeffectoptimalhealthcareoutcomesandmaximizethepotentialofthehealthsystem.”AdaptedfromtheCanadianInstitutesforHealthResearchdefinition,2001当前4页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregap

INTER-HEART:RiskofacuteMIassociatedwithriskfactorsintheoverallpopulation

YusufS.EuropeanSocietyofCardiologyCongress2004;August28-September1,2004;Munich,Germany.RiskfactorOddsratioadjustedforage,sex,andsmoking(99%CI)Oddsratioadjustedforall(99%CI)ApoB/ApoA-1(fifthquintilecomparedwithfirst)3.87(3.39-4.42)3.25(2.81-3.76)Currentsmoking2.95(2.72-3.20)2.87(2.58-3.19)Diabetes3.08(2.77-3.42)2.37(2.07-2.71)Hypertension2.48(2.30-2.68)1.91(1.74-2.10)Abdominalobesity2.22(2.03-2.42)1.62(1.45-1.80)Psychosocial2.51(2.15-2.93)2.67(2.21-3.22)Vegetableandfruitsdaily0.70(0.64-0.77)0.70(0.62-0.79)Exercise0.72(0.65-0.79)0.86(0.76-0.97)Alcoholintake0.79(0.73-0.86)0.91(0.82-1.02)Allcombined129.2(90.2-185.0)129.2(90.2-185.0)当前5页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregap

INTER-HEART:Population-AttributableRisk(PAR)AcuteMIintheoverallpopulation

RiskfactorPARadjustedforage,sex&smoking99%CI)PARadjustedforall(99%CI)ApoB/ApoA-1(fifthquintilecomparedwithfirst)54.1(49.6-58.6)49.2(43.8-54.5)Currentsmoking36.4(33.9-39.0)35.7(32.5-39.1)Diabetes12.3(11.2-13.5)9.9(8.5-11.5)Hypertension23.4(21.7-25.1)17.9(15.7-20.4)Abdominalobesity33.7(30.2-37.4)20.1(15.3-26.0)Psychosocial28.8(22.6-35.8)32.5(25.1-40.8)Vegetableandfruitsdaily12.9(10.0-16.6)13.7(9.9-18.6)Exercise25.5(20.1-31.8)12.2(5.5-25.1)Alcoholintake13.9(9.3-20.2)6.7(2.0-20.2)Allcombined90.4(88.1-92.4)90.4(88.1-92.4)YusufS.EuropeanSocietyofCardiologyCongress2004;August28-September1,2004;Munich,Germany.当前6页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapINTERHEART:SummaryNinesimpleriskfactorsarestronglyassociatedwithAMIworldwide.Theseriskfactorsareevenmoreimportantintheyoung,andtheireffectsareconsistentinmenandwomen,acrossallethnicgroupsandallregions.AbnormalApo-B/ApoA-1ratioandsmokingarethemostimportantriskfactorsandaccountfor>2/3ofthePAR.All9riskfactorsaccountfor>90%ofthePARgloballyandinmostregions.IMPLICATIONS:ImplementingpreventivestrategiesbasedonourcurrentknowledgewouldavertthemajorityofprematureCHDworldwide.当前7页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPreventionGoalsforCVDVariableGoalSmoking TotalCessationTotalDietaryFat/SaturatedFat<30%calories/<7%caloriesDietaryCholesterol<200mg/dayPhysicalActivity30-45min.moderateintensity5X/weekBodyWeightbyBodyMassindexInitialBMI

WeightLossGoal25-27.5BMI<25>27.510%relativeweightlossLDLcholesterol(primarygoal)1.6–2.2mmol/L(60-85mg/dL)HDLcholesterol(secondarygoal)1.0mmol/L(>40mg/dL)Triglyceride(secondarygoal)1.7mmol/L(<150mg/dL)BloodPressure<130/80mmHg(<120/80forLVD)DiabetesHbAlc<7.0%当前8页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPrimaryPreventionDietarymodification30%fat7%saturatedfat200mg/daycholesterol.Weightloss5-10%TBWPhysicalactivity30min5X/wkSmokingcessation当前9页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPotentialCumulativeImpactof1°PreventionStrategiesSmokingCessation2/3BPreduction20mmHg1/2LDLreduction1mmol/L1/6CumulativePrevention5/6当前10页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPotentialCumulativeImpactof

2°PreventionTreatmentsRRREventrateEventrateNone8%16%ASA25%6%12%

-Blockers25%4.5%9.0%Lipidlowering30%3.0%6.0%ACE-inhibitors25%2.3%4.6%CardiacRehab25%1.7%3.4%AdaptedfromYusuf,S.Twodecadesofprogressinpreventingvasculardisease.Lancet2002;360:2-3.

CUMULATIVEBENEFITSARELIKELYTOBEINEXCESSOF78%RRR,WHICHISSUBSTANTIAL当前11页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapCVD2°PreventionCocktailCAD,CVA,TIA,PVD,AAA,Type2DMSameDisease/SameRx:ASALipidTargetsTC<4.5LDL<2.0(1.8)HDL>1.2;TC/HDL<4TG<1.7

ACEinhibitorHOPETrialEUROPATrialß-blockerforpost-MI,HPTorCAD当前12页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapTop10EvidenceBased

AdvancesinCVDiseaseASA/Plavix-CAD/ACSUF/LMWHeparinACSThrombolytic/PCI-STEMIß-blockerpost-MIACE-i/ARBCHF/LVdysfunctionPostMIVasculardisease/DMAnticoagulationinatrialfibrillationLipidLowering2°-CAD,CVD,PVD,DM1°-RiskFactorsHTN(hypertension):

LDD/ß-blocker/ACE-i/ARB/long-actingCCB

IsolatedSystolicHTN>60:LDD/long-actingDHP-CCB/ARB(avoidß-blockeroralpha-blockerasinitialRx)

ß-blocker-CHF当前13页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapTop10FailurestoImplementEvidenceBasedAdvancesinCVDiseaseASA/Plavix-CAD/ACSUF/LMWHeparinACSThrombolytic/PCI-STEMIß-blockerpost-MIACE-i/ARBCHF/LVdysfunctionPostMIVasculardisease/DMAnticoagulationinatrialfibrillationLipidLowering2°-CAD,CVD,PVD,DM1°-RiskFactorsHTN(hypertension):

LDD/ß-blocker/ACE-i/ARB/long-actingCCB

IsolatedSystolicHTN>60:LDD/long-actingDHP-CCB/ARB(avoidß-blockeroralpha-blockerasinitialRx)

ß-blocker-CHF当前14页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapGoalsinCardiovascularPreventionIdentifyallpatientswhocouldbenefitStratifyaccordingtoallriskfactorsInitiatetherapyinallwherecost/benefitfavorableAchieveappropriatetargetsor%reductionsProvidelongtermfollow-uptoensureadherenceAchievemortality/morbiditybenefitsattainedinclinicaltrialsTargeteverypatientforoptimalriskstratificationandreduction当前15页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapWherecanwehavethegreatestimpactincardiovasculardisease?StrokepreventionHypertensioncontrolAnticoagulationinatrialfibrillationCADSecondarypreventioncocktailMedicalmanagementforsymptomsAppropriaterevascularizationCHFPatienteducationMedicalmanagementforprognosisandsymptomsAdmissionandreadmissionpreventionprograms当前16页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapWaystoinfluencepracticeConsensusguidelinesDidacticCMEWorkshopCMEPracticepatternreviewSpecificrecommendationsbylocalexpertsUsualchannelsofcommunicationReminderstrategiesEvidencebasedapplicationtools当前17页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapGuidelineImplementationBringtogethernationalexpertsDevelopguideline,consensusstatementorrecommendationPublicationDiffusionDisseminationImplementation当前18页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapKnowledgeEvolutionDATA

KnowledgeTranslation

INFORMATION

KnowledgeUtilization

ACTION当前19页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapOpportunitiestoImproveCareforPatientsWithCardiovascularDiseaseDespiteoverwhelmingclinicaltrialevidence,expertopinion,nationalguidelines,andavastarrayofeducationalconferences,evidence-based,life-savingtherapiescontinuetobeunderutilizedNewapproachestoimprovingtheuseofproven,guideline-recommended,life-savingtherapiesareclearlyneededFonarowGC.RevCardiovascMed.2002;3:S2-S10.

当前20页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapClinicalResearchtoClinicalPractice-LostinTranslation.

ClaudeLenfant,M.D.

NEJM349(9)868-874August282003…bothhealthprovidersandmembersofthepublic,arenotapplyingwhatweknow.…wearenotreapingthefullpublichealthbenefitsofourinvestmentinresearch.…thereisplentyofevidencethat"old"researchoutcomeshavebeenlostintranslationaswell.当前21页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapThecaseforknowledgetranslation:shorteningthejourneyfromevidencetoeffect.

BMJ

2003;327:33-35

(5

July03)

Davisetal

Alargegulfremainsbetweenwhatweknowandwhatwepractice.Suchvariationiscommonnotonlyinternationallybutwithincountries.Largegapsalsoexistbetweenbestevidenceandpracticeintheimplementationofguidelines.当前22页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapWhymostinterventionstoimprovephysicianprescribingdonotseemtowork.

MajumdarandSoumerai

CMAJ169(1)July82003InterventionsthatrelysolelyonpassiveinformationtransferareineffectiveActiveknowledgetranslationstrategiesareusuallyeffective,althoughtheeffectsaremodest.Interventionsthatincorporate2ormoredistinctstrategies(i.e.,thataremultifaceted)aremorelikelytowork当前23页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapTheCanadianCardiovascularSocietyandKnowledgeTranslation:

TurningBestEvidenceintoBestPractice

TremblayetalCanJCardiol2004;20(12):1195-1198.Estimatesofthesizeofthecaregapindicatethat30%to40%ofpatientsfailtoreceivetreatmentsofproveneffectiveness,20%to25%ofpatientsmayreceivecarethatisnotneededorispotentiallyharmful

当前24页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPatientHealthManagementPatientsFirst:ClosingtheHealthCareGapinCanadastartswithapremisenoonecandisagreewith:Thingscanbebetterinourhealthcaresystem,ineveryway.Dr.Montaguethengoesontoshowhowpatients,practitionersandpolicy-makerscanmakeincrementalimprovementsthatwillmakethingsbetter.Atthecentreofhisvisionisthepatient,andheprovidesablueprintthatwilldeliveroptimalhealthcareresultswithoutnecessarilyengenderingagreaterburdenonavailable

resources.当前25页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapAnalyzingtheCareGapEvidenceGapGuidelineGapDiffusionGapDisseminationGapImplementationGapAdherenceGapOutcomeGapRisingHealthCareCosts当前26页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapBarrierstoImplementingRiskFactorManagementinPatientsWithCHD

PhysicianisfocusedonacuteproblemsTimeconstraintsandlackofincentives,

includingreimbursementLackoftraining,includinginadequateknowledge

ofbenefitsandlackofprescriptionexperienceLackofresourcesandfacilitiesLackofspecialist–generalistcommunication;passingonresponsibilityAdaptedfromPearsonTAetal.JAmCollCardiol.1996;27:1039-1047.当前27页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapWhytheGap?Lackofinformation-knowledgegapInformationoverload-guidelineoverloadJurisdiction:Whosejobisit?ToobusytoreadrecommendationsPatientoverload/PhysicianshortageIssueoverload/PatientprioritiesLackoftoolsorresourcesConfusion-competingmarketingstrategiesMedico-legalimplications当前28页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapWhytheGap?UncertaintyInertiaJurisdictionEffectivenessResourcesContinuityAdherence当前29页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapAdherenceGapCostofmedicationsComplacency-patientandphysicianSideeffectsLackofunderstandingMediaimpact/fearsInfrequentmonitoringLackoffeedback当前30页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapEvidenceBased

ImplementationToolsCMECMICMIANewParadigmContinuingMedicalImplementation®当前31页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapcvtoolbox当前32页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapcvtoolbox当前33页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapcvtoolbox当前34页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapThreeProngedApproachCondensedevidencereviewandguidelinedistillationPatientinformationproductsImplementationtools当前35页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapPostMIDischargeSummary当前36页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapGuideforComprehensiveCardiovascularRiskReduction当前37页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapDyslipidemiaPackage当前38页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapLipidOptimizationTool当前39页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapHypertensionPackage当前40页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapHOPToITT

HypertensionCalendar当前41页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapDietInformationSheets当前42页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapDietInformationSheets当前43页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapOptimalManagementofAtrialFibrillation当前44页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapGuideforHFManagement当前45页,总共53页。©ContinuingMedicalImplementation®…...bridgingthecaregapContinuingMedicalImplementation®…...bridgingthecaregapMultipleModalitiesofDistributionTargetedmailingsHardcopy/photocopyReprint/re-orderDigitalcopyWebsiteCMEprogramsImplementationnetworks当前46页,总共53页。©ContinuingMedicalImplementation®…...bridgingth

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论